Screener
Lantern Pharma LTRN Q1 2026 Annual earnings
Reported May 15, 2026 · After market close
EPS-$0.30Beat by $0.06
EPS estimate-$0.36
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Lantern Pharma report Q1 2026 earnings?
- Lantern Pharma (LTRN) reported Q1 2026 earnings on May 15, 2026 after market close.
- What were Lantern Pharma's Q1 2026 revenue and EPS?
- Lantern Pharma reported eps of $-0.30 for Q1 2026.
- Did Lantern Pharma beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.36 by $0.06.
- How did Lantern Pharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 28.6% from $-0.42.
- Where can I find Lantern Pharma's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-023200) and the 10-K/A periodic report (0001493152-26-019713) directly on SEC EDGAR. The filing index links above go to sec.gov.
